|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2023 |
12/06/2023 - 8:00am to 9:00am EST |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2023 |
12/13/2023 - 8:00am to 9:00am EST |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2023 |
12/20/2023 - 8:00am to 9:00am EST |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2023 |
12/27/2023 - 8:00am to 9:00am EST |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2023 |
05/31/2023 - 8:00am to 9:00am EDT |
|
Heterogenous Outcomes of Epstein-Barr Virus Infection |
02/08/2023 - 8:00am to 9:00am EST |
|
Hypereosinophilia / Liver-directed therapy for metastatic colon cancer |
05/24/2023 - 8:00am to 9:00am EDT |
|
Improving Immune Therapies for Blood, Marrow and Node Cancer Patients |
03/01/2023 - 8:00am to 9:00am EST |
|
Investigating the non-canonical role of Hippo Kinase, serine/threonine kinase 3 (STK3) in prostate cancer / Investigating the Impact of ABL Kinase Signaling on Epigenetic Reprogramming in Metastatic Triple Negative Breast Cancer |
08/02/2023 - 8:00am to 9:00am EDT |
|
Leveraging Evolutionary and Ecological Principles to Overcome Cancer Therapy Resistanceherapy resistance |
01/11/2023 - 8:00am to 9:00am EST |
Facebook
Twitter
LinkedIn
Forward